Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Determination of trimethylamine-N-oxide in combination with l-carnitine and γ-butyrobetaine in human plasma by UPLC/MS/MS.

Grinberga S, Dambrova M, Latkovskis G, Strele I, Konrade I, Hartmane D, Sevostjanovs E, Liepinsh E, Pugovics O.

Biomed Chromatogr. 2015 Apr 14. doi: 10.1002/bmc.3477. [Epub ahead of print]

PMID:
25873316
2.

Iodine deficiency during pregnancy: a national cross-sectional survey in Latvia.

Konrade I, Kalere I, Strele I, Makrecka-Kuka M, Jekabsone A, Tetere E, Veisa V, Gavars D, Rezeberga D, Pīrāgs V, Lejnieks A, Dambrova M.

Public Health Nutr. 2015 Mar 3:1-8. [Epub ahead of print]

PMID:
25731595
3.

A cross-sectional survey of urinary iodine status in Latvia.

Konrade I, Neimane L, Makrecka M, Strele I, Liepinsh E, Lejnieks A, Vevere P, Gruntmanis U, Pīrāgs V, Dambrova M.

Medicina (Kaunas). 2014;50(2):124-9. doi: 10.1016/j.medici.2014.06.003. Epub 2014 Jun 27.

4.

Acute anti-hyperglycaemic effects of an unripe apple preparation containing phlorizin in healthy volunteers: a preliminary study.

Makarova E, Górnaś P, Konrade I, Tirzite D, Cirule H, Gulbe A, Pugajeva I, Seglina D, Dambrova M.

J Sci Food Agric. 2015 Feb;95(3):560-8. doi: 10.1002/jsfa.6779. Epub 2014 Jul 4.

PMID:
24917557
5.

Meldonium decreases the diet-increased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis.

Dambrova M, Skapare-Makarova E, Konrade I, Pugovics O, Grinberga S, Tirzite D, Petrovska R, Kalvins I, Liepins E.

J Clin Pharmacol. 2013 Oct;53(10):1095-8. doi: 10.1002/jcph.135. Epub 2013 Jul 25. No abstract available.

PMID:
23893520
6.

Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients.

Skapare E, Konrade I, Liepinsh E, Strele I, Makrecka M, Bierhaus A, Lejnieks A, Pirags V, Dambrova M.

J Diabetes Complications. 2013 May-Jun;27(3):262-7. doi: 10.1016/j.jdiacomp.2012.12.002. Epub 2013 Jan 23.

PMID:
23351995
7.

Identification of glyoxalase 1 polymorphisms associated with enzyme activity.

Peculis R, Konrade I, Skapare E, Fridmanis D, Nikitina-Zake L, Lejnieks A, Pirags V, Dambrova M, Klovins J.

Gene. 2013 Feb 15;515(1):140-3. doi: 10.1016/j.gene.2012.11.009. Epub 2012 Nov 29.

PMID:
23201419
8.

Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues BID in outpatient settings.

Pīrāgs V, El Damassy H, Dąbrowski M, Gönen MS, Račická E, Martinka E, Giaconia J, Stefanski A; B001 Study Investigators.

Int J Clin Pract. 2012 Nov;66(11):1033-41. doi: 10.1111/j.1742-1241.2012.03001.x. Erratum in: Int J Clin Pract. 2013 Jun;67(6):e1.

PMID:
23067027
9.

Seasonal iodine deficiency in Latvian school children.

Konrade I, Dambrova M, Makrecka M, Neimane L, Strele I, Liepinsh E, Lejnieks A, Vevere P, Gruntmanis U, Pirags V.

Thyroid. 2012 Oct;22(10):1088-9. doi: 10.1089/thy.2011.0506. Epub 2012 Sep 4. No abstract available.

PMID:
22947352
10.

Glyoxalase 1 and glyoxalase 2 activities in blood and neuronal tissue samples from experimental animal models of obesity and type 2 diabetes mellitus.

Skapare E, Konrade I, Liepinsh E, Makrecka M, Zvejniece L, Svalbe B, Vilskersts R, Dambrova M.

J Physiol Sci. 2012 Nov;62(6):469-78. doi: 10.1007/s12576-012-0224-9. Epub 2012 Aug 15.

PMID:
22893478
11.

Seasonal iodine deficiency in Latvian school children.

Konrade I, Dambrova M, Makrecka M, Neimane L, Strele I, Liepinsh E, Lejnieks A, Vevere P, Gruntmanis U, Pīrāgs V.

Thyroid. 2012 Jul 5. [Epub ahead of print]

PMID:
22765259
12.

High L-carnitine concentrations do not prevent late diabetic complications in type 1 and 2 diabetic patients.

Liepinsh E, Skapare E, Vavers E, Konrade I, Strele I, Grinberga S, Pugovics O, Dambrova M.

Nutr Res. 2012 May;32(5):320-7. doi: 10.1016/j.nutres.2012.03.010. Epub 2012 Apr 25.

PMID:
22652370
13.

Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy.

Bierhaus A, Fleming T, Stoyanov S, Leffler A, Babes A, Neacsu C, Sauer SK, Eberhardt M, Schnölzer M, Lasitschka F, Neuhuber WL, Kichko TI, Konrade I, Elvert R, Mier W, Pirags V, Lukic IK, Morcos M, Dehmer T, Rabbani N, Thornalley PJ, Edelstein D, Nau C, Forbes J, Humpert PM, Schwaninger M, Ziegler D, Stern DM, Cooper ME, Haberkorn U, Brownlee M, Reeh PW, Nawroth PP.

Nat Med. 2012 Jun;18(6):926-33. doi: 10.1038/nm.2750. Erratum in: Nat Med. 2012 Sep;18(9):1445. Lasischka, Felix [corrected to Lasitschka, Felix].

PMID:
22581285
14.

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.

Punthakee Z, Bosch J, Dagenais G, Diaz R, Holman R, Probstfield J, Ramachandran A, Riddle M, Rydén LE, Zinman B, Afzal R, Yusuf S, Gerstein H; TIDE Trial Investigators.

Diabetologia. 2012 Jan;55(1):36-45. doi: 10.1007/s00125-011-2357-4. Epub 2011 Oct 29.

PMID:
22038523
15.

Mildronate treatment alters γ-butyrobetaine and l-carnitine concentrations in healthy volunteers.

Liepinsh E, Konrade I, Skapare E, Pugovics O, Grinberga S, Kuka J, Kalvinsh I, Dambrova M.

J Pharm Pharmacol. 2011 Sep;63(9):1195-201. doi: 10.1111/j.2042-7158.2011.01325.x. Epub 2011 Jul 6.

PMID:
21827492
16.

Flow cytometric analysis of glyoxalase-1 expression in human leukocytes.

Skapare E, Riekstina U, Liepinsh E, Konrade I, Makrecka M, Maurina B, Dambrova M.

Cell Biochem Funct. 2011 Mar;29(2):171-4. doi: 10.1002/cbf.1723. Epub 2011 Feb 2.

PMID:
21370249
17.

Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial.

Davies M, Lavalle-González F, Storms F, Gomis R; AT.LANTUS Study Group.

Diabetes Obes Metab. 2008 May;10(5):387-99. doi: 10.1111/j.1463-1326.2008.00873.x. Epub 2008 Mar 18.

PMID:
18355327
18.

sRAGE and esRAGE are not associated with peripheral or autonomic neuropathy in type 2 diabetes.

Humpert PM, Papadopoulos G, Schaefer K, Djuric Z, Konrade I, Morcos M, Nawroth PP, Bierhaus A.

Horm Metab Res. 2007 Dec;39(12):899-902. Epub 2007 Nov 28.

PMID:
18046662
19.

Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity.

Rudofsky G Jr, Reismann P, Grafe IA, Konrade I, Djuric Z, Tafel J, Buchbinder S, Zorn M, Humpert PM, Hamann A, Morcos M, Nawroth PP, Bierhaus A.

Horm Metab Res. 2007 Sep;39(9):665-71.

PMID:
17846974
20.

Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient.

Humpert PM, Bärtsch U, Konrade I, Hammes HP, Morcos M, Kasper M, Bierhaus A, Nawroth PP.

Exp Clin Endocrinol Diabetes. 2005 Oct;113(9):538-40.

PMID:
16235157
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk